<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="230394">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00079963</url>
  </required_header>
  <id_info>
    <org_study_id>62378DK</org_study_id>
    <nct_id>NCT00079963</nct_id>
  </id_info>
  <brief_title>Gender, Obesity, C-Reactive Protein, and Oxidative Stress</brief_title>
  <official_title>Gender, Obesity, C-Reactive Protein, and Oxidative Stress</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of California, Berkeley</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kaiser Permanente</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized placebo-controlled trial will test whether supplementing with vitamins C and
      E can lower markers of inflammation and oxidative stress in healthy adults. We will examine
      whether one antioxidant vitamin is more effective than another, and whether gender or body
      fat influence the treatment effects. We will also determine whether gender, body fat, or
      menopausal status are associated with baseline concentrations of inflammation and oxidative
      stress markers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will be given 1000 mg vitamin C or 800 IU vitamin E daily for 60 days.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>April 2004</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in high-sensitivity C-reactive protein (hsCRP)</measure>
    <time_frame>8-week intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in blood pressure</measure>
    <time_frame>8-week intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in self-reported stress and psychosocial factors</measure>
    <time_frame>8-week intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in oxidative stress biomarkers (F2-Isoprostanes, malondialdehyde)</measure>
    <time_frame>8-week intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Association of gender, body fat, menopausal status with baseline concentrations of inflammation and oxidative stress biomarkers.</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">396</enrollment>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>X</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin C</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Y</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin E</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Z</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin C</intervention_name>
    <description>1000 mg/day</description>
    <arm_group_label>X</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin E</intervention_name>
    <description>800 IU/day</description>
    <arm_group_label>Y</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Z</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Nonsmoker and not passively exposed

          -  Males and females 18 year and older

          -  Able to take vitamin supplements

          -  Able to take acetominophen instead of aspirin or NSAIDs during the study

        Exclusion criteria:

          -  Pregnancy or lactation

          -  History of ever smoking or passive smoke exposure in the last year

          -  Active liver disease; history of HIV/AIDS, diabetes, kidney stones, hemochromatosis,
             or autoimmune diseases; heart disease, stroke, or cancer in the last 5 years

          -  User of prescribed anti-inflammatory or lipid-lowering medications, oral
             contraceptives, hormone replacement therapy, or blood-thinning drugs

          -  User of iron supplements or vitamin E at 600 IU per day or more

          -  Consumption of more than 2 alcoholic beverages per day
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gladys Block, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California at Berkeley</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California, Berkeley School of Public Health</name>
      <address>
        <city>Berkeley</city>
        <state>California</state>
        <zip>94720-7360</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <lastchanged_date>March 21, 2016</lastchanged_date>
  <firstreceived_date>March 18, 2004</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Berkeley</investigator_affiliation>
    <investigator_full_name>Gladys Block</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin E</mesh_term>
    <mesh_term>Tocopherols</mesh_term>
    <mesh_term>Tocotrienols</mesh_term>
    <mesh_term>alpha-Tocopherol</mesh_term>
    <mesh_term>Ascorbic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
